SCHEMBL18708802

SCHEMBL18708802

CC1=CNc2ncnc(C)c2CC1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DRD1 P21728 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30159359 0.72 DRD1 (0.49) DRD1
SCHEMBL795294 0.72 DRD1 (0.49) DRD1
SCHEMBL12382071 0.61 SRC (0.46)
SCHEMBL12333209 0.59 HTR2A (0.35) DRD1
SCHEMBL1586120 0.58 DRD1 (0.48) DRD1
SCHEMBL16079383 0.58 KDM4E (0.45) DRD1
SCHEMBL12284090 0.58
SCHEMBL15127493 0.57 KDM4E (0.44) DRD1
SCHEMBL15219375 0.57 KDR (0.39) DRD1
SCHEMBL23599065 0.56 ALDH1A1 (0.39) DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3613743-A1 PROCESSES FOR THE PREPARATION OF 1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE DERIVATIVES Intellikine, LLC (US) 2020-02-26 EP disclosed
EP-3441392-A1 A PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION Intellikine, LLC (US) 2019-02-13 EP disclosed
EP-3150609-A1 PROCESS FOR PREPARING CERTAIN CHEMICAL ENTITIES Intellikine, LLC (US) 2017-04-05 EP disclosed